Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regulation of Insulin Secretion by GLP-1 Receptor
NCT02844907Phase 4Terminated
- Sponsor
- VA Office of Research & Development
- Start
- Jul 2018
- Primary completion
- Dec 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of exendin 9-39, sponsored by VA Office of Research & Development. Started Jul 2018; status: terminated.
02
Drugs
exendin 9-39
Beyond the preview
Go deeper on NCT02844907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02844907.